IE 11 is not supported. For an optimal experience visit our site on another browser.

CEO to lower drug price after controversy


CNBC’s Meg Tirrell and LSU Health Sciences Center’s Dr. Corey Hebert discuss Turing Pharmaceutical CEO Martin Shkreli’s decision to lower the price of prescription drug Daramprim after raising the price from $13.50 to $750 yesterday.